Table 1.
Baseline characteristics.
| AHI < 15 | AHI ≥ 15 | Between Group Comparison (p-Value) | |
|---|---|---|---|
| Number of individuals | 23 | 23 | |
| Male participants (%) | 7 (30) | 7 (30) | |
| Female participants (%) | 16 (70) | 16 (70) | |
| Age, in years (± SD) | 42.57 ± 11.44 | 43.43 ± 11.96 | 0.214 |
| BMI, in kg/m2 (± SD) | 37.35 ± 3.88 | 37.87 ± 4.74 | 0.532 |
| Hypertension (n (%)) | 10 (43) | 8 (35) | |
| Diabetes mellitus (n (%)) | 2 (9) | 2 (9) | |
| Insulin intake (n(%)) | 0 (0) | 0 (0) | |
| Metformin intake (n (%)) | 3 (13) | 2 (9) | |
| Pulmonary disorders (n (%)) | 2 (9) | 2 (9) | |
| Hypothyroidism (n (%)) | 4 (17) | 6 (25) | |
| Levothyroxine intake (n (%)) | 5 (22) | 6 (25) | |
| Number of non-smokers (%) | 16 (70) | 15 (65) | |
| Number of active smokers (%) | 7 (30) | 8 (35) |
BMI-body mass index. Note: In both groups, there were two diabetics taking Metformin. One additional patient in group “AHI < 15” was taking Metformin for dietary reasons but did not have diabetes.